Healthcare Equipment and Supplies
Company Overview of Solta Medical, Inc.
Solta Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets energy-based medical device systems for aesthetic applications primarily in North America, the Asia Pacific, Europe, and the Middle East. It offers Fraxel re:pair system for use in dermatological procedures requiring ablation, coagulation, and resurfacing of soft tissue, as well as for rhytides, pigmentation, dyschromia, fine lines, acne, surgical scars, deeper lines, wrinkles, and actinic keratoses; and Clear + Brilliant system, a treatment to improve skin texture and help prevent the signs of aging skin. The company also provides Thermage CPT system that provides non-invasive treatment options...
25881 Industrial Boulevard
Hayward, CA 94545
Founded in 1996
Key Executives for Solta Medical, Inc.
Chief Executive Officer, President and Director
Compensation as of Fiscal Year 2017.
Solta Medical, Inc. Key Developments
Solta Medical Receives FDA 510(K) Clearance for Thermage FLX™ System, Newest Generation Skin Smoothing Technology
Oct 4 17
Solta Medical announced that its Thermage FLX™ System received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to non-invasively smooth skin on the face, eyes and body. Thermage FLX is the newest generation of Thermage® technologies known for non-invasively reducing the appearance of fine lines and wrinkles. The system uses patented radiofrequency technology to create a uniform heating effect in the deep collagen-rich layers of the skin. This gentle heating tightens existing collagen and stimulates the production of new collagen, all with little-to-no downtime for the patient. The Thermage FLX features a new optimized energy delivery algorithm, known as AccuREP™ technology, which automatically measures and precisely tunes the amount of energy delivered to the patient and treatment area. The system also features a new vibrating hand-piece to help enhance patient comfort, and a new, larger treatment tip that reduces treatment time by 25%. The non-invasive treatment of addressing the look and feel of aging skin using radiofrequency energy was first introduced by Thermage more than 15 years ago. Since that time, the technology has continued to evolve, and to date, two million Thermage treatments for women and men of all ethnicities have been performed. The new Thermage FLX system is expected to be commercially available before the end of 2017.
Valeant Reportedly Works With Morgan Stanley To Sell Solta Medical And Obagi Medical
Jun 14 16
Valeant Pharmaceuticals International, Inc. (NYSE:VRX) has engaged Morgan Stanley for the sale of Obagi Medical Products, Inc. and Solta Medical, Inc. to raise cash to reduce debt, according to people familiar with the matter. The two sale could fetch as much as $500 million and the sale process could start as early as this week, the people added. Bloomberg added that representatives at Valeant and Morgan Stanley declined to comment.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|